Your browser doesn't support javascript.
loading
MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Hirano, Michitada; So, Yusei; Tsunekawa, Shin; Kabata, Mio; Ohta, Sho; Sagara, Hiroshi; Sankoda, Nao; Taguchi, Jumpei; Yamada, Yosuke; Ukai, Tomoyo; Kato, Makoto; Nakamura, Jiro; Ozawa, Manabu; Yamamoto, Takuya; Yamada, Yasuhiro.
Affiliation
  • Hirano M; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • So Y; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Tsunekawa S; Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Aichi, Japan.
  • Kabata M; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Ohta S; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Sagara H; Medical Proteomics Laboratory, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Sankoda N; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Taguchi J; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamada Y; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Ukai T; Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Kato M; Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Aichi, Japan.
  • Nakamura J; Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Aichi, Japan.
  • Ozawa M; Laboratory of Reproductive Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamamoto T; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Yamada Y; AMED-CREST, AMED, Tokyo, Japan.
Nat Metab ; 4(2): 254-268, 2022 02.
Article in En | MEDLINE | ID: mdl-35145326
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Diabetes Mellitus, Experimental / Glucagon-Secreting Cells / Insulin-Secreting Cells Limits: Animals / Humans Language: En Journal: Nat Metab Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Diabetes Mellitus, Experimental / Glucagon-Secreting Cells / Insulin-Secreting Cells Limits: Animals / Humans Language: En Journal: Nat Metab Year: 2022 Document type: Article Affiliation country: